The 10,000 square foot research and training facility in Sunnyvale, California, and the 15,000 square foot R&D facility in San Carlos, California, will be used to pursue new medical robotics indications.
According to a news release, Noah Medical — founded by medical robotics entrepreneur Jian Zhang — aims to utilize its new, state-of-the-art facilities to pursue disruptive applications of robotics that have been “left unaddressed by current platforms.”
The Sunnyvale facility will be used to complete the testing of Noah Medical’s first commercial robotic system, the Galaxy System. The Galaxy System was designed as a robotic-assisted platform for minimally invasive peripheral lung navigation, with Noah Medical aiming to file for FDA clearance later in 2022. The facility will also serve as the company’s sales and customer training site ahead of commercialization efforts.
Noah Medical’s San Carlos facility, which sits less than one mile from the company’s San Carlos headquarters, will expand its R&D capabilities and engineering team, improving investigational capabilities and new pipeline product development.
“We envision a world in which next-generation medical robots help diagnose disease and treat patients early to ensure minimal hospital stays and quick recoveries,” Zhang, Noah Medical’s founder and CEO, said in the release. “These facilities are just the latest step in our journey towards that reality and they will prove critical to the development and commercialization of our first platform.”
